Therapeutic drug monitoring of oral targeted antineoplastic drugs Anna Mueller-SchoellStefanie L. GroenlandCharlotte Kloft Review Open access 09 November 2020 Pages: 441 - 464
Correction to: Therapeutic drug monitoring of oral targeted antineoplastic drugs Anna Mueller-SchoellStefanie L. GroenlandCharlotte Kloft Correction 15 December 2020 Pages: 465 - 465
Interventions to optimize prescribed medicines and reduce their misuse in chronic non-malignant pain: a systematic review Aziza AleneziAsma YahyoucheVibhu Paudyal Review Open access 30 October 2020 Pages: 467 - 490
Effectiveness of hypoxia-induced factor prolyl hydroxylase inhibitor for managing anemia in chronic kidney disease: a systematic review and meta-analysis Min LiJiarong LanPeixin Duan Review 07 November 2020 Pages: 491 - 507
Appropriate use of essential medicines in the elderly: a comparison of the WHO essential medicines list and PIM criteria Xin MaXuxu YinWei Liu Review 12 November 2020 Pages: 509 - 516
ImpaCt of aspirin regimen on THrombin generation in diabEtic patients with acute coronary syndrome: CARTHaGE-ACS trial Amine BoussofaraLobna LaroussiSalem Kachboura Clinical Trial 06 August 2020 Pages: 517 - 526
Safety, pharmacodynamic, and pharmacokinetic characterization of vericiguat: results from six phase I studies in healthy subjects Michael BoettcherDirk ThomasCorina Becker Clinical Trial Open access 30 October 2020 Pages: 527 - 537
The PRECIS-2 tool seems not to be useful to discriminate the degree of pragmatism of medicine masked trials from that of open-label trials Rafael Dal-Ré Clinical Trial 26 October 2020 Pages: 539 - 546
Protective effect of flumazenil infusion in severe acute benzodiazepine toxicity: a pilot randomized trial Akram Sadat RazavizadehNasim ZamaniHossein Hassanian-Moghaddam Clinical Trial 30 October 2020 Pages: 547 - 554
Correction to: Protective effect of flumazenil infusion in severe acute benzodiazepine toxicity: a pilot randomized trial Akram Sadat RazavizadehNasim ZamaniHossein Hassanian-Moghaddam Correction 26 February 2021 Pages: 555 - 556
The motivations, barriers, and sociodemographic characteristics of healthy Chinese volunteers in phase I research Zejuan WangGang ChenJin Wang Pharmacoeconomics 13 November 2020 Pages: 557 - 568
Correlation between single-nucleotide polymorphisms and statin-induced myopathy: a mixed-effects model meta-analysis Qian XiangXiao-Dan ZhangYi-Min Cui Pharmacokinetics and Disposition 04 November 2020 Pages: 569 - 581
Population-based meta-analysis of chloroquine: informing chloroquine pharmacokinetics in COVID-19 patients Xueting YaoXiaoyu YanDongyang Liu Pharmacokinetics and Disposition Open access 13 November 2020 Pages: 583 - 593
Predicting the presence and mechanism of busulfan drug-drug interactions in hematopoietic stem cell transplantation using pharmacokinetic interaction network–based molecular structure similarity and network pharmacology Chenxia HaoXiaoqin MaWanhua Yang Pharmacokinetics and Disposition 11 November 2020 Pages: 595 - 605
Optimal sampling strategies for darunavir and external validation of the underlying population pharmacokinetic model Gabriel StillemansLeila BelkhirLaure Elens Pharmacokinetics and Disposition Open access 11 November 2020 Pages: 607 - 616
Use of tramadol and other analgesics following media attention and risk minimization actions from regulators: a Danish nationwide drug utilization study Anne Mette Skov SørensenLotte RasmussenAnton Pottegård Pharmacoepidemiology and Prescription Open access 28 October 2020 Pages: 617 - 624
Off-label use of dexmedetomidine in paediatric anaesthesiology: an international survey of 791 (paediatric) anaesthesiologists Camille E. van HoornRobert B. FlintJurgen C. de Graaff Pharmacoepidemiology and Prescription Open access 29 October 2020 Pages: 625 - 635
Patients’ contribution to drug safety in Catalonia: the interest of personal feelings on adverse drug reactions J. Riera-ArnauL. A. Alvarado AguirreG. Cereza García Pharmacoepidemiology and Prescription 10 November 2020 Pages: 637 - 642
Incidence, preventability, and causality of adverse drug reactions at a university hospital emergency department Mirjam KauppilaJanne T. BackmanOuti Lapatto-Reiniluoto Pharmacoepidemiology and Prescription Open access 13 November 2020 Pages: 643 - 650
